Analgesics and laxatives as risk factors for urothelial cancer - Results of the BUS (Berlin Urothelial Cancer Study);Analgetika und Laxantien als Risikofaktoren fur Krebs der ableitenden Harnwege - Ergebnisse der Berliner Urothelkarzinom-Studie (BUS)

Sozial- und Praventivmedizin

Volumn 44, Issue 3, 1999, Pages 117-125

  Bronder, Elisabeth ^a   Klimpel, Andreas ^b   Helmert, Uwe ^b   Greiser, Eberhard ^b   Molzahn, Martin ^b   Pommer, Wolfgang ^b  

^a Inst Nieren und H   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; LAXATIVE; NON PRESCRIPTION DRUG; PARACETAMOL; PHENACETIN; PYRAZOLONE;

ARTICLE; BLADDER CANCER; CANCER RISK; DRUG CONTROL; HUMAN; KIDNEY PELVIS CARCINOMA; MEDICINAL PLANT; RETROSPECTIVE STUDY; SENNA; URETER CANCER; UROGENITAL TRACT TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; BERLIN; CARCINOMA, RENAL CELL; CATHARTICS; COCARCINOGENESIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; KIDNEY NEOPLASMS; KIDNEY PELVIS; MALE; MIDDLE AGED; RISK; SMOKING; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 0032771050     PISSN: 03038408     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01299400     Document Type: Article

References (25)

1. Bengtsson U, Angervall L, Ekman H, Lehmann L. Transitional cell tumors of the renal pelvis in analgesic abusers. Scand J Urol Nephrol 1968; 2:145-150.
2. Angervall L, Bengtsson U, Zetterlund CG and Zsigmond M. Renal pelvic carcinoma in a Swedish district with abuse of a Phenacetin-containing drug. Brit J Urol 1969; 41:401-405.
3. Mihatsch MJ, Knüsli C. Phenacetin abuse and malignant tumors. Klin Wschr 1982; 60:1339-1349.
4. Leistenschneider W, Nagel R, Steffens J. Nierenbeckentumoren und Phenacetinabusus. Akt Urol 1983; 14:15-20.
5. Steffens J, Nagel R. Nierenbeckenund Harnleitertumore. Beobachtungen an 170 Patienten (1948-1981). Akt Urol 1986; 17: 171-176.
6. McCredie M, Stewart JH, Ford JM, McLennan RA. Phenacetin-containing analgesics and cancer of the bladder or renal pevis in women. Brit J Urology 1983; 55:220-224.
7. McCredie M, Stewart JH, Day NE. Different roles for phenacetin and paracetamol in cancer of the kidney and renal pelvis. Int J Cancer 1993; 53:245-249.
8. Jensen OM, Knudsen JB, Tomasson H, Sorensen BL. The Copenhagen case-control study of renal pelvis and ureter cancer: Role of analgesics. Int J Cancer 1989; 44: 965-968.
9. Linet MS, Chow W-H, McLaughlin JK et al. Analgesics and cancers of the renal pelvis and ureter. Int J Cancer 1995; 62:15-18.
10. Piper JM, Tonaskia PH, Matanoski GM. Heavy Phenacetin use and bladder cancer in women aged 20 to 49 years. N Engl J Med 1985; 313:292-305.
11. Kunze E, Chang-Claude J, Frentzel-Beyme R. Life style and occupational risk factors for bladder cancer in Germany. Cancer 1992; 69:1777-1790.
12. Kunze E, Chang-Claude J, Frentzel-Beyme R. Ätiologie, Pathogenese und Epidemiologie von Urotheltumoren. Verh Dtsch Ges Path 1993; 77:147-156.
13. Bolm-Audorff U, Jöckel K-H, Kilguss B, Pohlabeln H, Siepenkothen T. Bösartige Tumoren der ableitenden Harnwege und Risiken am Arbeitsplatz. Schriftenreihe der Bundesanstalt für Arbeitsschutz - Forschung - Fb 697. Bundesanstalt für Arbeitsschutz (Hg) Dortmund 1993.
14. Siegers C-P, Hertzberg-Lottin von E, Otte M, Schneider B. Anthranoid laxative abuse - a risk for colorectal cancer? Gut 1993; 34:1099-1101.
15. Kune GA. Laxative use not a risk for colorectal cancer: data from the Melbourne colorectal cancer study. Z Gastroenterol 1993; 31: 140-143.
16. Loew D, Bergmann U, Schmidt M, Überla KH. Anthranoidlaxantien. Ursache für Kolonkarzinom? Deutsche Apotheker Zeitung 1994; 134:3180-3183.
17. Loew D, Bergmann U, Dirschedl P, Schmidt M, Überla KH. Anthranoidlaxanzien. Studien über das karzinogene Risiko. Deutsche Apotheker Zeitung 1997; 137:2088-2092.
18. Pommer W, Bronder E, Greiser E et al. Regular analgesic intake and the risk of end-stage renal failure. Am J Nephrol 1989; 9:403-412.
19. Bronder E, Klimpel A, Pommer W, Molzahn M. Daten zum chronischen Schmerzmittelgebrauch. Soz Praeventivmed 1990; 35:147-151.
20. Breslow NE, Day NE. Statistical methods in cancer research. Volume 1. The analysis of case-control studies. Lyon IARC Scientific Publication No.32, 1980: 191-279.
21. Schlesselman JJ. Case-Control-Studies: Design, Conduct, Analysis. New York, University Press, 1982: 171-280.
22. SAS Institute Inc. SAS/STAT Software: The PHREG Procedure, Preliminary Documentation. Cary 1996.
23. Wainscoat JS, Finn R. Possible Role of Laxatives in Analgesic Nephropathy. British Medical J 1974; 4: 697-698.
24. Violon C. Belgian (Chinese herb) nephropathy: Why? J Pharm Belg 1997; 52:7-27.
25. Bronder E, Klimpel A, Pommer W, Molzahn M. Anthranoidlaxantien. Risiko relativiert. Deutsche Apotheker Zeitung (Briefe) 1997; 137: 3489.